BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 178255)

  • 1. Regional immunotherapy in resectable squamous cell lung carcinoma. Analysis of a randomized study.
    Roeslin N; Lang JM; Morand G; Wihlm JM; Witz JP
    Cancer Immunol Immunother; 1982; 13(3):174-5. PubMed ID: 6925982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.
    Bakker W; Nijhuis-Heddes JM; van der Velde EA
    Cancer Immunol Immunother; 1986; 22(2):155-9. PubMed ID: 3719595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant specific immunotherapy of resectable squamous cell lung carcinoma. Analysis at the eighth year.
    Takita H; Hollinshead A; Hart T; Bhayana J; Adler R; Rao U; Moskowitz R; Ramundo M
    Cancer Immunol Immunother; 1985; 20(3):231-5. PubMed ID: 3904977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An anti-neoplastic glycan isolated from Mycobacterium bovis (BCG vaccine).
    Wang R; Klegerman ME; Marsden I; Sinnott M; Groves MJ
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):867-72. PubMed ID: 7487943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of immunologic status of patients receiving BCG therapy for malignant disease.
    Gross NJ; Eddie-Quartey AC
    Cancer; 1976 May; 37(5):2183-93. PubMed ID: 769946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of immunotherapy in the combined treatment of lung cancer].
    Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
    Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
    Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
    Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL; McLaren JR; Skeen MJ
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune status in lung cancer: effects of BCG immunotherapy.
    Gross NJ; Eddie-Quartey AC
    Am Rev Respir Dis; 1976 Apr; 113(4):457-64. PubMed ID: 178255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
    Azuma I; Yamamura Y
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of lung cancer.
    Zubrod CG; Selawry O
    Adv Intern Med; 1978; 23():451-67. PubMed ID: 204171
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.